The FDA's controversial approval of menthol-flavored e-cigarettes has sparked criticism from public health advocates while supporting the vaping industry's claim that e-cigarettes can aid smokers in quitting tobacco. The decision, which includes products from NJOY, a subsidiary of Altria Group, signals a shift in the agency's approach to vaping products. Despite the approval, the FDA emphasized that tobacco products, including e-cigarettes, are not safe and can be harmful and addictive. This decision comes amid legal challenges and scrutiny over the agency's regulation of e-cigarettes, particularly flavored products that appeal to youth. The Biden administration's delay on banning menthol cigarettes further complicates the regulatory landscape. As the FDA faces pressure to review more e-cigarette applications, critics question the agency's priorities in light of its authorization of products from a major tobacco company while delaying or denying those from independent manufacturers.